The present invention relates to conversion of gaseous alkanes to liquid hydrocarbons and, more particularly, in one or more embodiments, to a method and system that includes bromination of alkanes followed by conversion of the brominated alkanes to hydrocarbons wherein bromine recovery includes electrolysis.
Natural gas which primarily comprises methane and other light alkanes has been discovered in large quantities throughout the world. Many of the locales in which natural gas has been discovered are far from populated regions which have significant gas pipeline infrastructure or market demand for natural gas. Due to the low density of natural gas, its transportation in gaseous form by pipeline or as compressed gas in vessels is expensive. Accordingly, practical and economic limits exist to the distance over which natural gas may be transported in gaseous form. Cryogenic liquefaction of natural gas (LNG) is often used to more economically transport natural gas over large distances. However, this LNG process may be expensive and there are limited regasification facilities in only a few countries that are equipped to import LNG.
A number of techniques may be used to convert alkanes found in natural gas to liquids that may be more easily transported and, thus, generate additional value from natural gas. One technique for this conversion is a bromine-based process that may include bromination of alkanes to form brominated alkanes, and conversion of the brominated alkanes to hydrocarbons over an appropriate catalyst. An undesirable by-product from both the bromination and conversion steps in this process is hydrogen bromide. Before the hydrocarbons produced in this bromine-based process may be recovered as a liquid product, the hydrogen bromide may need to be separated from the hydrocarbons. The bromine may then be recovered from the hydrogen bromide and recycled within the process. In one instance, an aqueous technique may be used that includes scrubbing the hydrogen bromide from the hydrocarbon stream with an aqueous stream followed by neutralization of the dissolved hydrogen bromide to form a metal bromide salt. The metal bromide salt may then be oxidized to recover the bromine. In another instance, a dry technique may be used that includes reaction of the hydrogen bromide with a metal oxide to form a metal bromide salt, which may then be oxidized to recover the bromine.
The present invention relates to conversion of gaseous alkanes to liquid hydrocarbons and, more particularly, in one or more embodiments, to a method and system that includes bromination of alkanes followed by conversion of the brominated alkanes to hydrocarbons wherein bromine recovery includes electrolysis.
An embodiment includes a method comprising: providing a stream comprising halogenated alkanes; forming synthesis products comprising hydrocarbons and hydrogen bromide from synthesis reactants comprising at least a portion of the halogenated alkanes; and recovering at least a portion of the bromine, the recovering comprising electrolysis.
Another embodiment includes a method comprising: providing a stream comprising a hydrogen halide; converting at least a portion of the hydrogen halide to at least molecular halogen using gas phase electrolysis; providing a stream comprising hydrocarbons; and forming halogenation products comprising halogenated alkanes and hydrogen halide by reacting at least a portion of the molecular halogen with at least a portion of the hydrocarbons.
Still another embodiment includes a method comprising: providing a stream comprising halogenated alkanes; forming synthesis products comprising hydrocarbons and hydrogen halide from synthesis reactants comprising at least a portion of the halogenated alkanes; separating the at least a portion of the hydrogen halide from the synthesis products; and converting at least a portion of the separated hydrogen halide to at least molecular halogen using liquid phase electrolysis.
The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
These drawings illustrate certain aspects of some of the embodiments of the present invention, and should not be used to limit or define the invention.
The present invention relates to conversion of gaseous alkanes to liquid hydrocarbons and, more particularly, in one or more embodiments, to a method and system that includes bromination of alkanes followed by conversion of the brominated alkanes to hydrocarbons wherein bromine recovery includes electrolysis.
There may be many potential advantages to the methods and systems of the present invention, only some of which are alluded to herein. One of the many potential advantages may be that bromine may be recovered and recycled using electrolysis in a bromine-based process for the production of liquid hydrocarbons. As previously mentioned, hydrogen bromide is generally an undesired byproduct in the bromine-based process for producing liquid hydrocarbons. In accordance with embodiments of the present invention, electric energy may be used to electrolyze the produced hydrogen bromide to form hydrogen and bromine. Accordingly, the bromine may be recovered and recycled within the process.
Referring to
As illustrated, gaseous feed stream 12 comprising alkanes may be combined with bromine stream 14, and the resulting mixture may be introduced into bromination reactor 2. While
Bromine stream 14 generally comprises bromine and may be at a pressure, for example, in the range of about 1 atm to about 100 atm and, alternatively, of about 1 atm to about 30 atm. In certain embodiments, the bromine may be dry, in that it is substantially free of water vapor. In certain embodiments, the bromine present in bromine stream 14 may be in a gaseous state, a liquid state, or a mixture thereof. As illustrated, bromine stream 14 contains bromine from liquid-phase electrolysis unit 10 that is recovered and recycled within the process. While not illustrated in
As previously mentioned, gaseous feed stream 12 and bromine stream 14 may be combined and introduced into bromination reactor 2. The mole ratio of the alkanes in gaseous feed stream 12 to the bromine in bromine stream 14 may be, for example, in excess of 2.5:1. While not illustrated, in certain embodiments, bromination reactor 2 may have an inlet pre-heater zone for heating the mixture of the alkanes and bromine to a reaction initiation temperature, for example, in the range of about 250° C. to about 400° C.
In bromination reactor 2, the alkanes may be reacted with the bromine to form brominated alkanes and hydrogen bromide. By way of example, methane may react in bromination reactor 2 with bromine to form brominated methane and hydrogen bromide. In the case of methane reacting with bromine, the formation of mono-brominated methane occurs in accordance with the following general reaction:
CH4+Br2→CH3Br+HBr (1)
This reaction generally occurs with a fairly high selectivity to mono-brominated methane. For instance, in the case of the non-catalyzed bromination of methane operated with excess methane in the range of about 4:1 to about 9:1, the reaction selectivity generally may be in the range of about 70% to about 80% mono-brominated methane and about 20% to about 30% di-brominated methane, on a molar basis. To improve the selectivity with respect to mono-brominated methane, the bromination reaction may be run with a larger excess of methane. In general, it is believed that only very small amounts of tri-brominated methane and tetra-brominated methane should also be formed in the bromination reaction. Higher alkanes, such as ethane, propane, and butane, may also be readily also readily brominated resulting in mono- and multi-brominated alkanes, such as brominated ethane, brominated propane, and brominated butane.
In certain embodiments, the bromination reaction in bromination reactor 2 occurs exothermically, for example, at a temperature in the range of about 250° C. to about 600° C. and at a pressure in the range of about 1 atm to about 100 atm and, alternatively, of about 1 atm to about 30 atm. The upper limit of this temperature range may be greater than the upper limit of the reaction initiation temperature range to which the feed mixture may be heated due to the exothermic nature of the bromination reaction. As will be appreciated by those of ordinary skill in the art, with the benefit of this disclosure, the reaction in bromination reactor 2 may be a homogeneous gas phase reaction or a heterogeneous (catalytic) reaction. Examples of suitable catalysts that may be utilized in bromination reactor 10 include, but are not limited to, platinum, palladium, or supported non-stoichiometric metal oxy-halides such as FeOxBry or FeOxCly or supported stoichiometric metal oxy-halides such as TaOF3, NbOF3, ZrOF2, SbOF3 as described in Olah, et al, J. Am. Chem. Soc. 1985, 107, 7097-7105.
As set forth above, the bromine fed into bromination reactor 2 may be dry, in certain embodiments of the present invention. Elimination of substantially all water vapor from the bromination reaction in bromination reactor 2 should substantially eliminate the formation of unwanted carbon dioxide, thereby increasing the selectivity of the alkane bromination to brominated alkanes and potentially eliminating the large amount of waste heat generated in the formation of carbon dioxide from alkanes. Further, elimination of substantially all water vapor should minimize hydrothermal degradation of downstream catalysts that may be used, in certain embodiments of the present invention.
As illustrated in
In synthesis reactor 4, the brominated alkanes may be reacted exothermically in the presence of a catalyst to form product hydrocarbons and additional hydrogen bromide. The reaction may occur, for example, at a temperature in the range of about 150° C. to about 500° C. and a pressure in the range of about 1 atm to 100 atm and, alternatively of about 1 atm to about 30 atm. The product hydrocarbons generally may include, for example, C3, C4, and C5+ gasoline-range and heavier hydrocarbon, including, for example, alkanes and aromatics, as well as olefins, such as ethylene, propylene, and the like. Example processes for the production of product hydrocarbons that include bromination followed by a synthesis reaction are described in more detail in U.S. Pat. No. 7,244,867, U.S. Pat. No. 7,348,464, and U.S. Patent Pub. No. 2006/0100469, the entire disclosures of which incorporated herein by reference.
The catalyst may be any of a variety of suitable materials for catalyzing the conversion of the brominated alkanes to higher molecular weight hydrocarbons. In certain embodiments, synthesis reactor 4 may comprise a fixed bed of the catalyst. A fluidized-bed of synthesis catalyst may also be used in certain circumstances, particularly in larger applications and may have certain advantages, such as constant removal of coke and a steady selectivity to product composition. Examples of suitable catalysts include a fairly wide range of materials that have the common functionality of being acidic ion-exchangers and which also contain a synthetic crystalline alumino-silicate oxide framework. In certain embodiments, a portion of the aluminum in the crystalline alumino-silicate oxide framework may be substituted with magnesium, boron, gallium and/or titanium. In certain embodiments, a portion of the silicon in the crystalline alumino-silicate oxide framework may be optionally substituted with phosphorus. The crystalline alumino-silicate catalyst generally may have a significant anionic charge within the crystalline alumino-silicate oxide framework structure which may be balanced, for example, by cations of elements selected from the group H, Li, Na, K or Cs or the group Mg, Ca, Sr or Ba. Although zeolitic catalysts may be commonly obtained in a sodium form, a protonic or hydrogen form (via ion-exchange with ammonium hydroxide, and subsequent calcining) is preferred, or a mixed protonic/sodium form may also be used. The zeolite may also be modified by ion exchange with other alkali metal cations, such as Li, K, or Cs, with alkali-earth metal cations, such as Mg, Ca, Sr, or Ba, or with transition metal cations, such as Ni, Cu, Fe, Mn, V, and W or with rare-earth metal cations such as La or Ce. Such subsequent ion-exchange, may replace the charge-balancing counter-ions, but furthermore may also partially replace ions in the oxide framework resulting in a modification of the crystalline make-up and structure of the oxide framework. The crystalline alumino-silicate or substituted crystalline alumino-silicate may include a microporous or mesoporous crystalline aluminosilicate, but, in certain embodiments, may include a synthetic microporous crystalline zeolite, and, for example, being of the MFI structure such as ZSM-5. Moreover, the crystalline alumino-silicate or substituted crystalline alumino-silicate, in certain embodiments, may be subsequently impregnated with an aqueous solution of a Mg, Ca, Sr, or Ba, La or Ce salt. In certain embodiments, the salts may be a halide salt, such as a bromide salt, such as MgBr2 or CeBr3. Optionally, the crystalline alumino-silicate or substituted crystalline alumino-silicate may also contain between about 0.1 to about 1 weight % Pt, about 0.1 to 5 weight % Pd, or about 0.1 to about 5 weight % Ni in the metallic state. Although, such materials are primarily initially crystalline, it should be noted that some crystalline catalysts may undergo some loss of crystallinity either due to initial ion-exchange or impregnation or due to operation at the reaction conditions or during regeneration and hence may also contain significant amorphous character, yet still retain significant, and in some cases improved activity.
The particular catalyst used in synthesis reactor 4 will depend, for example, upon the particular product hydrocarbons that are desired. For example, when product hydrocarbons having primarily C3, C4 and C5+ gasoline-range aromatic compounds and heavier hydrocarbon fractions are desired, a ZSM-5 zeolite catalyst may be used. When it is desired to produce product hydrocarbons comprising a mixture of olefins and C5+ products, an X-type or Y-type zeolite catalyst or SAPO zeolite catalyst may be used. Examples of suitable zeolites include an X-type, such as 10-X, or Y-type zeolite, although other zeolites with differing pore sizes and acidities, may be used in embodiments of the present invention.
The temperature at which synthesis reactor 4 is operated is one parameter in determining the selectivity of the reaction to the particular product hydrocarbons desired. Where, for example, an X-type or Y-type zeolite or SAPO zeolite catalyst is used and it is desired to produce olefins, synthesis reactor 4 may be operated at a temperature within the range of about 250° C. to about 500° C. Temperatures above about 450° C. in synthesis reactor 4 may result in increased yields of light hydrocarbons, such as undesirable methane and also deposition of coke, whereas lower temperatures generally should increase yields of ethylene, propylene, butylene and heavier molecular weight hydrocarbons. In the case of the alkyl bromide reaction over the 10 X zeolite catalyst, for example, it is believed that cyclization reactions also may occur such that the C7+ fractions contain substantial substituted aromatics. At increasing temperatures approaching about 400° C., for example, it is believed that brominated methane conversion generally should increase towards about 90% or greater; however, selectivity towards C5+ hydrocarbons generally should decrease with increased selectivity toward lighter products, such as olefins. At temperatures exceeding about 550° C., for example, it is believed that a high conversion of brominated methane to methane and carbonaceous coke occurs. In the temperature range of between about 300° C. and about 450° C., as a byproduct of the reaction, a lesser amount of coke probably will build up on the catalyst over time during operation, causing a decline in catalyst activity over a range of hours, up to hundreds of hours, depending on the reaction conditions and the composition of the feed gas. Conversely, temperatures at the lower end of the range (e.g., below about 300° C.), may also contribute to coking due to a reduced rate of desorption of heavier products from the catalyst. Hence, operating temperatures within the range of about 250° C. to about 500° C., but preferably in the range of about 350° C. to about 450° C. in synthesis reactor 4 should generally balance increased selectivity of the desired olefins and C5+ hydrocarbons and lower rates of deactivation due to carbon formation, against higher conversion per pass, which should minimize the quantity of catalyst, recycle rates and equipment size required.
Where, for example, the product hydrocarbons desired are primarily C3, C4, and C5+ gasoline-range and heavier hydrocarbon fractions, synthesis reactor 4 may be operated at a temperature within the range of about 150° C. to about 450° C. Temperatures above about 300° C. in synthesis reactor 4 may result in increased yields of light hydrocarbons, whereas lower temperatures generally may increase yields of heavier molecular weight hydrocarbons. By way of example, at the low end of the temperature range with brominated methane reacting over the ZSM-5 zeolite catalyst at temperatures as low as about 150° C., significant brominated methane conversion on the order of about 20% may occur, with a high selectivity towards C5+ hydrocarbons. In the case of the brominated methane reaction over the ZSM-5 zeolite catalyst, for example, cyclization reactions also occur such that the C7+ fractions may be primarily comprise substituted aromatics. At increasing temperatures approaching about 300° C., for example, brominated methane conversion generally should increase towards about 90% or greater; however, selectivity towards C5+ hydrocarbons generally may decrease and selectivity towards lighter products, particularly undesirable methane, may increase. Surprisingly, benzene, ethane or C2-C3 olefin components are not typically present, or present in only very small quantities, in the reaction effluent, in accordance with certain embodiments, such as when a ZSM-5 catalyst is used at temperatures of about 390° C. However, at temperatures approaching about 450° C., for example, almost complete conversion of brominated methane to methane and carbonaceous coke may occur. In the operating temperature range of between about 350° C. and about 420° C., as a byproduct of the reaction, a small amount of carbon may build up on the catalyst over time during operation, potentially causing a decline in catalyst activity over a range of hours, up to several days, depending on the reaction conditions and the composition of the feed gas. It is believed that higher reaction temperatures (e.g., above about 420° C.), associated with the formation of methane, favor the thermal cracking of brominated alkanes and formation of carbon or coke and hence an increase in the rate of deactivation of the catalyst. Conversely, temperatures at the lower end of the range (e.g., below about 350° C.) may also contribute to coking due to a reduced rate of desorption of heavier products from the catalyst. Hence, operating temperatures within the range of about 150° C. to about 450° C., but preferably in the range of about 350° C. to about 420° C., and most preferably, in the range of about 370° C. to about 400° C., in synthesis reactor 4 should generally balance increased selectivity of the desired C5+ hydrocarbons and lower rates of deactivation due to carbon formation, against higher conversion per pass, which minimizes the quantity of catalyst, recycle rates and equipment size required.
The catalyst may be periodically regenerated in situ, by isolating synthesis reactor 4 from the normal process flow and purging with an inert gas, for example, at a pressure in a range of about 1 atm to about 5 atm bar at an elevated temperature in the range of about 400° C. to about 650° C. to remove unreacted material adsorbed on the catalyst insofar as is practical. Then, the deposited heavy products, coke, or both may be oxidized to CO2, CO, and H2O by addition of air or inert gas-diluted oxygen to synthesis reactor 4, for example, at a pressure in the range of about 1 atm to about 5 atm at an elevated temperature in the range of about 400° C. to about 650° C. The oxidation products and residual air or inert gas may be vented from synthesis reactor 4 during the regeneration period. However, as the regeneration off-gas may contain small amounts of bromine-containing species, as well as excess unreacted oxygen, the regeneration gas effluent may be directed into the oxidation portion of the process, wherein the bromine-containing species may be converted to elemental bromine and recovered for re-use within the process.
As illustrated in
As set forth above, the process of
One example of a suitable liquid that may be used to scrub the hydrogen bromide from the product hydrocarbons includes water. In these embodiments, the hydrogen bromide dissolves into the water and is at least partially ionized, forming an aqueous acid solution. Another example of a suitable liquid that may be used to scrub the hydrogen bromide from the product hydrocarbons includes an aqueous partially oxidized metal bromide salt solution containing metal hydroxide species, metal oxy-bromide species, metal oxide species, or mixtures thereof. The hydrogen bromide dissolved in the partially oxidized metal bromide salt solution should be neutralized to form metal bromide salt in electrolysis feed stream 20 that may be removed from hydrogen bromide separator unit 6. Examples of suitable metals of the bromide salt include Fe(III), Cu(II), and Zn(II), as these metals may be less expensive and may be oxidized at lower temperatures, for example, in the range of about 120° C. to about 200° C. However, other metals that form oxidizable bromide salts may also be used. In certain embodiments, alkaline earth metals which may also form bromide salts and hydroxides, such as Ca(II) or Mg(II) may be used.
As noted above, hydrocarbon stream 22 comprising the product hydrocarbons may be removed from hydrogen bromide separator unit 6. In general, hydrocarbon stream 22 comprises the excess unreacted alkanes and the product hydrocarbons from which the hydrogen bromide was separated. As illustrated in
At least a portion of the residual vapor effluent from product recovery unit 8 may be recovered as alkane recycle stream 26. Alkane recycle stream 26 may comprise, for example, methane and possibly other unreacted lower molecular weight alkanes. As illustrated, alkane recycle stream 26 may be recycled and combined with gaseous feed stream 12. In certain embodiments, alkane recycle stream 26 that is recycled may be at least 1.5 times the feed gas molar volume. While not illustrated in
As set forth above, the hydrogen bromide may be separated from the product hydrocarbons in hydrogen bromide separator unit 6. As illustrated in
In liquid-phase electrolysis unit 10, bromine may be recovered from the hydrogen bromide or the metal bromide salt present in electrolysis feed stream 20. Electric energy may be used, in the hydrogen bromide electrolysis embodiments, to electrolyze at least a portion of the hydrogen bromide to form elemental bromine and hydrogen and, in the metal bromide salt electrolysis embodiments, to electrolyze at least a portion of the metal bromide to form the elemental bromine and the metal, metal ion in the reduced state or metal hydroxide. The presence of a reducible metal ion in solution may have the advantage of reducing the cathodic overpotential required, hence minimizing power requirements as compared to the electrolysis of aqueous acid. In the electrolysis of an aqueous hydrochloric acid solution (HCl), the Uhde process may be used and may also possibly be adapted for the electrolysis of the aqueous hydrobromic acid, e.g., the hydrogen bromide dissolved in electrolysis feed stream 20.
While not illustrated in
By way of example, the electrolysis of hydrogen bromide may occur in an aqueous hydrobromic acid solution in the substantial absence of a metal ion, in accordance with the following general half-reactions occurring at the anode and cathode electrodes, respectively, of the electrolysis cells:
2Br(−)→Br2+2e− (2)
2H(+)+2e−→H2 (3)
By way of further example, the electrolysis of a metal bromide salt (e.g., Fe(III)Br3) may occur in accordance with the following general half-reactions occurring at the anode and cathode electrodes, respectively, of the electrolysis cells:
2Br(−)→Br2+2e− (4)
2Fe(+3)+2e−→2Fe(+2) (5)
and 2H2O+2e−=H2+2OH(−)
Where Fe(+3) and Fe(+2) may further react with OH(−) to form iron hydroxides.
Accordingly, bromine may be generated in liquid-phase electrolysis unit 10, in accordance with embodiments of the present invention. Bromine stream 14 comprising the bromine may be removed from liquid-phase electrolysis unit 10 and supplied to bromination reactor 2. Accordingly, bromide may be recovered and recycled within the process, in accordance with embodiments of the present invention. Furthermore, dependent upon whether hydrogen bromide, a metal bromide salt, or both is supplied to liquid-phase electrolysis unit, a reduced metal ion, hydroxyl ion, or metal hydroxide, a hydrogen, or two or more of these should also be generated in liquid-phase electrolysis unit 10. Accordingly, hydrogen/reduced metal ion stream 28 comprising the hydrogen, the reduced metal ion, hydroxyl ion or metal hydroxide, or two or more of these may also be removed from liquid-phase electrolysis unit 10. Among other uses, the hydrogen may be recycled within the process or used in additional processes, such as petroleum refining or chemical synthesis. Furthermore, water stream 30 comprising the water in which the hydrogen bromide (or metal bromide salt) is electrolyzed may also be removed from liquid-phase electrolysis unit 10.
In one embodiment, one or more of the electrolysis cells in liquid-phase electrolysis unit 10 may be operated in an air-depolarized mode in which air is passed over the cathode. In the air-depolarized mode embodiments, hydrogen bromide electrolysis should produce water at the cathode and metal bromide salt electrolysis should produce a metal hydroxide or metal oxide at the cathode. By way of example, the electrolysis of hydrogen bromide in air-depolarized mode embodiments may produce water at the cathode and partially depolarize the electrode according to the following reaction:
The air-depolarized embodiments may be particularly useful where there is no local need for hydrogen. In certain embodiments, two or more electrolysis cells may be used in parallel with one or more operated with an air-depolarized cathode producing water rather than hydrogen.
By way of further example, the electrolysis of a metal bromide salt (e.g., Fe(III)Br3) in air-depolarized mode embodiments may produce free hydroxide and partially depolarize the electrode according to the following overall reaction:
Fe(+3a)+3/2O2+3H(+)+6e−=Fe(OH)3 (7)
Referring to
As illustrated in
In the illustrated embodiment, synthesis outlet stream 18 may be introduced to product recovery unit 8 to recover, for example, the product hydrocarbons as liquid product stream 24. Liquid product stream 24 may comprise, for example, C5+ hydrocarbons, including alkanes and substituted aromatics. In certain embodiments, liquid product stream 32 may comprise olefins, such as ethylene, propylene, and the like. In certain embodiments, liquid product stream 24 may comprise various hydrocarbons in the liquefied petroleum gas and gasoline-fuels range, which may include a substantial aromatic content, significantly increasing the octane value of the hydrocarbons in the gasoline-fuels range.
Vapor effluent stream 22 from product recovery unit 8 may be supplied to vapor-phase electrolysis unit 32. In certain embodiments, vapor effluent stream 22 may comprise methane and possibly other unreacted lower molecular weight alkanes. In addition, in the embodiment illustrated in
In vapor-phase electrolysis unit 32, bromine may be recovered from the hydrogen bromide present in vapor effluent stream 22. Electric energy may be used to electrolyze at least a portion of the hydrogen bromide to form elemental bromine and hydrogen. The electrolysis of hydrogen bromide may generally occur in accordance with the half-reactions illustrated previously in equations (2) and (3). An example process for the vapor-phase electrolysis of hydrogen bromide is described in U.S. Pat. No. 5,411,641, the entire disclosure of which is incorporated herein by reference. While not illustrated in
Accordingly, bromine may be recovered in vapor-phase electrolysis unit 32, in accordance with embodiments of the present invention. Recycle stream 34 may be removed from vapor-phase electrolysis unit 32. Recycle stream 34 may comprise, for example, the recovered bromine as well as methane and potentially other unreacted lower molecular weight alkanes that were not recovered in product recovery unit 8. As illustrated recycled stream 34 may be recycled and combined with gaseous feed stream 12. In certain embodiments, recycle stream 34 that is recycled may contain alkanes in an amount that is at least 1.5 times the feed gas molar volume. While not illustrated in
As noted above, hydrogen also should be produced in vapor-phase electrolysis unit 32. Accordingly, hydrogen stream 36 comprising the hydrogen may also be removed from vapor-phase electrolysis unit 32. Among other uses, the hydrogen may be recycled within the process or used in additional processes, such as petroleum refining or chemical synthesis. In certain embodiments, if one or more cells of vapor-phase electrolysis unit 32 are operating in an air-depolarized mode, the produced water also may be removed from vapor-phase electrolysis unit 32.
As set forth above with respect to
Referring to
Referring to
Referring to
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified, and all such variations are considered within the scope and spirit of the present invention. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood as referring to the power set (the set of all subsets) of the respective range of values, and set forth every range encompassed within the broader range of values. Moreover, the indefinite articles “a” or “an”, as used in the claims, are defined herein to mean one or more than one of the element that it introduces. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
This application is based on and claims priority to U.S. Provisional Patent Application No. 61/061,475, filed Jun. 13, 2008, the entire contents of which are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2168260 | Heisel et al. | Aug 1939 | A |
2246082 | Vaughan et al. | Jun 1941 | A |
2320257 | Beekhuis | May 1943 | A |
2488083 | Gorin et al. | Nov 1949 | A |
2536457 | Mugdan | Jan 1951 | A |
2666024 | Low et al. | Jan 1954 | A |
2677598 | Crummett et al. | May 1954 | A |
2941014 | Rothweiler et al. | Jun 1960 | A |
3076784 | Schulte-Huermann et al. | Feb 1963 | A |
3172915 | Borkowski et al. | Mar 1965 | A |
3246043 | Rosset et al. | Apr 1966 | A |
3254023 | Miale et al. | May 1966 | A |
3273964 | Rosset | Sep 1966 | A |
3291708 | Juda | Dec 1966 | A |
3294846 | Livak et al. | Dec 1966 | A |
3310380 | Lester | Mar 1967 | A |
3314762 | Hahn | Apr 1967 | A |
3346340 | Louvar et al. | Oct 1967 | A |
3353916 | Lester | Nov 1967 | A |
3353919 | Stockman | Nov 1967 | A |
3379506 | Massonne et al. | Apr 1968 | A |
3468968 | Baker et al. | Sep 1969 | A |
3496242 | Berkowitz et al. | Feb 1970 | A |
3562321 | Borkowski et al. | Feb 1971 | A |
3598876 | Bloch | Aug 1971 | A |
3615265 | Gartner | Oct 1971 | A |
3657367 | Blake et al. | Apr 1972 | A |
3670037 | Dugan | Jun 1972 | A |
3673264 | Kuhn | Jun 1972 | A |
3679758 | Schneider | Jul 1972 | A |
3702886 | Argauer et al. | Nov 1972 | A |
3705196 | Turner | Dec 1972 | A |
3799997 | Schmerling | Mar 1974 | A |
3816599 | Kafes | Jun 1974 | A |
3865886 | Schindler et al. | Feb 1975 | A |
3876715 | McNulty et al. | Apr 1975 | A |
3879473 | Stapp | Apr 1975 | A |
3879480 | Riegel et al. | Apr 1975 | A |
3883651 | Woitun et al. | May 1975 | A |
3886287 | Kobayashi et al. | May 1975 | A |
3894103 | Chang et al. | Jul 1975 | A |
3894104 | Chang et al. | Jul 1975 | A |
3894105 | Chang et al. | Jul 1975 | A |
3894107 | Butter et al. | Jul 1975 | A |
3907917 | Forth | Sep 1975 | A |
3919336 | Kurtz | Nov 1975 | A |
3920764 | Riegel et al. | Nov 1975 | A |
3923913 | Antonini et al. | Dec 1975 | A |
3928483 | Chang et al. | Dec 1975 | A |
3965205 | Garwood et al. | Jun 1976 | A |
3974062 | Owen et al. | Aug 1976 | A |
3987119 | Kurtz et al. | Oct 1976 | A |
3992466 | Plank et al. | Nov 1976 | A |
4006169 | Anderson et al. | Feb 1977 | A |
4011278 | Plank et al. | Mar 1977 | A |
4025571 | Lago | May 1977 | A |
4025572 | Lago | May 1977 | A |
4025575 | Chang et al. | May 1977 | A |
4025576 | Chang et al. | May 1977 | A |
4035285 | Owen et al. | Jul 1977 | A |
4035430 | Dwyer et al. | Jul 1977 | A |
4039600 | Chang | Aug 1977 | A |
4044061 | Chang et al. | Aug 1977 | A |
4046825 | Owen et al. | Sep 1977 | A |
4049734 | Garwood et al. | Sep 1977 | A |
4052471 | Pearsall | Oct 1977 | A |
4052472 | Givens et al. | Oct 1977 | A |
4058576 | Chang et al. | Nov 1977 | A |
4060568 | Rodewald | Nov 1977 | A |
4071753 | Fulenwider et al. | Jan 1978 | A |
4072733 | Hargis et al. | Feb 1978 | A |
4087475 | Jordan | May 1978 | A |
4088706 | Kaeding | May 1978 | A |
4092368 | Smith | May 1978 | A |
4105755 | Darnell et al. | Aug 1978 | A |
4110180 | Nidola et al. | Aug 1978 | A |
4117251 | Kaufhold et al. | Sep 1978 | A |
4129604 | Tsao | Dec 1978 | A |
4133838 | Pearson | Jan 1979 | A |
4133966 | Pretzer et al. | Jan 1979 | A |
4138440 | Chang et al. | Feb 1979 | A |
4143084 | Kaeding et al. | Mar 1979 | A |
4156698 | Dwyer et al. | May 1979 | A |
4169862 | Eden | Oct 1979 | A |
4172099 | Severino | Oct 1979 | A |
4187255 | Dodd | Feb 1980 | A |
4191618 | Coker et al. | Mar 1980 | A |
4194990 | Pieters et al. | Mar 1980 | A |
4197420 | Ferraris et al. | Apr 1980 | A |
4219604 | Kakimi et al. | Aug 1980 | A |
4219680 | Konig et al. | Aug 1980 | A |
4249031 | Drent et al. | Feb 1981 | A |
4252687 | Dale et al. | Feb 1981 | A |
4270929 | Dang Vu et al. | Jun 1981 | A |
4272338 | Lynch et al. | Jun 1981 | A |
4282159 | Davidson et al. | Aug 1981 | A |
4300005 | Li | Nov 1981 | A |
4300009 | Haag et al. | Nov 1981 | A |
4301253 | Warren | Nov 1981 | A |
4302619 | Gross et al. | Nov 1981 | A |
4307261 | Beard, Jr. et al. | Dec 1981 | A |
4308403 | Knifton | Dec 1981 | A |
4311865 | Chen et al. | Jan 1982 | A |
4317800 | Sloterdijk et al. | Mar 1982 | A |
4317934 | Seemuth | Mar 1982 | A |
4317943 | Knifton | Mar 1982 | A |
4320241 | Frankiewicz | Mar 1982 | A |
4333852 | Warren | Jun 1982 | A |
4347391 | Campbell | Aug 1982 | A |
4350511 | Holmes et al. | Sep 1982 | A |
4356159 | Norval et al. | Oct 1982 | A |
4371716 | Paxson et al. | Feb 1983 | A |
4373109 | Olah | Feb 1983 | A |
4376019 | Gamlen et al. | Mar 1983 | A |
4380682 | Leitert et al. | Apr 1983 | A |
4384159 | Diesen | May 1983 | A |
4389391 | Dunn, Jr. | Jun 1983 | A |
4410714 | Apanel | Oct 1983 | A |
4412086 | Beard, Jr. et al. | Oct 1983 | A |
4418236 | Cornelius et al. | Nov 1983 | A |
4431856 | Daviduk et al. | Feb 1984 | A |
4433189 | Young | Feb 1984 | A |
4433192 | Olah | Feb 1984 | A |
4439409 | Puppe et al. | Mar 1984 | A |
4440871 | Lok et al. | Apr 1984 | A |
4443620 | Gelbein et al. | Apr 1984 | A |
4462814 | Holmes et al. | Jul 1984 | A |
4465884 | Degnan et al. | Aug 1984 | A |
4465893 | Olah | Aug 1984 | A |
4467130 | Olah | Aug 1984 | A |
4467133 | Chang et al. | Aug 1984 | A |
4489210 | Judat et al. | Dec 1984 | A |
4489211 | Ogura et al. | Dec 1984 | A |
4492657 | Heiss | Jan 1985 | A |
4496752 | Gelbein et al. | Jan 1985 | A |
4497967 | Wan | Feb 1985 | A |
4499314 | Seddon et al. | Feb 1985 | A |
4506105 | Kaufhold | Mar 1985 | A |
4509955 | Hayashi | Apr 1985 | A |
4513092 | Chu et al. | Apr 1985 | A |
4513164 | Olah | Apr 1985 | A |
4523040 | Olah | Jun 1985 | A |
4524227 | Fowles et al. | Jun 1985 | A |
4524228 | Fowles et al. | Jun 1985 | A |
4524231 | Fowles et al. | Jun 1985 | A |
4538014 | Miale et al. | Aug 1985 | A |
4538015 | Miale et al. | Aug 1985 | A |
4540826 | Banasiak et al. | Sep 1985 | A |
4543434 | Chang | Sep 1985 | A |
4544781 | Chao et al. | Oct 1985 | A |
4547612 | Tabak | Oct 1985 | A |
4550217 | Graziani et al. | Oct 1985 | A |
4550218 | Chu | Oct 1985 | A |
4568660 | Klosiewicz | Feb 1986 | A |
4579977 | Drake | Apr 1986 | A |
4579992 | Kaufhold et al. | Apr 1986 | A |
4579996 | Font Freide et al. | Apr 1986 | A |
4587375 | Debras et al. | May 1986 | A |
4588835 | Torii et al. | May 1986 | A |
4590310 | Townsend et al. | May 1986 | A |
4599474 | Devries et al. | Jul 1986 | A |
4605796 | Isogai et al. | Aug 1986 | A |
4605803 | Chang et al. | Aug 1986 | A |
4621161 | Shihabi | Nov 1986 | A |
4621164 | Chang et al. | Nov 1986 | A |
4633027 | Owen et al. | Dec 1986 | A |
4634800 | Withers, Jr. et al. | Jan 1987 | A |
4642403 | Hyde et al. | Feb 1987 | A |
4642404 | Shihabi | Feb 1987 | A |
4652688 | Brophy et al. | Mar 1987 | A |
4654449 | Chang et al. | Mar 1987 | A |
4655893 | Beale | Apr 1987 | A |
4658073 | Tabak | Apr 1987 | A |
4658077 | Kolts et al. | Apr 1987 | A |
4665259 | Brazdil et al. | May 1987 | A |
4665267 | Barri | May 1987 | A |
4665270 | Brophy et al. | May 1987 | A |
4675410 | Feitler et al. | Jun 1987 | A |
4690903 | Chen et al. | Sep 1987 | A |
4695663 | Hall et al. | Sep 1987 | A |
4696985 | Martin | Sep 1987 | A |
4704488 | Devries et al. | Nov 1987 | A |
4704493 | Devries et al. | Nov 1987 | A |
4709108 | Devries et al. | Nov 1987 | A |
4720600 | Beech, Jr. et al. | Jan 1988 | A |
4720602 | Chu | Jan 1988 | A |
4724275 | Hinnenkamp et al. | Feb 1988 | A |
4735747 | Ollivier et al. | Apr 1988 | A |
4737594 | Olah | Apr 1988 | A |
4748013 | Saito et al. | May 1988 | A |
4762596 | Huang et al. | Aug 1988 | A |
4769504 | Noceti et al. | Sep 1988 | A |
4774216 | Kolts et al. | Sep 1988 | A |
4775462 | Imai et al. | Oct 1988 | A |
4777321 | Harandi et al. | Oct 1988 | A |
4781733 | Babcock et al. | Nov 1988 | A |
4783566 | Kocal et al. | Nov 1988 | A |
4788369 | Marsh et al. | Nov 1988 | A |
4788377 | Chang et al. | Nov 1988 | A |
4792642 | Rule et al. | Dec 1988 | A |
4795732 | Barri | Jan 1989 | A |
4795737 | Rule et al. | Jan 1989 | A |
4795843 | Imai et al. | Jan 1989 | A |
4795848 | Teller et al. | Jan 1989 | A |
4804797 | Minet et al. | Feb 1989 | A |
4804800 | Bortinger et al. | Feb 1989 | A |
4808763 | Shum | Feb 1989 | A |
4814527 | Diesen | Mar 1989 | A |
4814532 | Yoshida et al. | Mar 1989 | A |
4814535 | Yurchak | Mar 1989 | A |
4814536 | Yurchak | Mar 1989 | A |
4849562 | Buhs et al. | Jul 1989 | A |
4849573 | Kaeding | Jul 1989 | A |
4851602 | Harandi et al. | Jul 1989 | A |
4851606 | Ragonese et al. | Jul 1989 | A |
4886925 | Harandi | Dec 1989 | A |
4886932 | Leyshon | Dec 1989 | A |
4891463 | Chu | Jan 1990 | A |
4895995 | James, Jr. et al. | Jan 1990 | A |
4899000 | Stauffer | Feb 1990 | A |
4899001 | Kalnes et al. | Feb 1990 | A |
4899002 | Harandi et al. | Feb 1990 | A |
4902842 | Kalnes et al. | Feb 1990 | A |
4925995 | Robschlager | May 1990 | A |
4929781 | James, Jr. et al. | May 1990 | A |
4939310 | Wade | Jul 1990 | A |
4939311 | Washecheck et al. | Jul 1990 | A |
4939314 | Harandi et al. | Jul 1990 | A |
4945175 | Hobbs et al. | Jul 1990 | A |
4950811 | Doussain et al. | Aug 1990 | A |
4950822 | Dileo et al. | Aug 1990 | A |
4956521 | Volles | Sep 1990 | A |
4962252 | Wade | Oct 1990 | A |
4973776 | Allenger et al. | Nov 1990 | A |
4973786 | Karra | Nov 1990 | A |
4982024 | Lin et al. | Jan 1991 | A |
4982041 | Campbell | Jan 1991 | A |
4988660 | Campbell | Jan 1991 | A |
4990696 | Stauffer | Feb 1991 | A |
4990711 | Chen et al. | Feb 1991 | A |
5001293 | Nubel et al. | Mar 1991 | A |
5004847 | Beaver et al. | Apr 1991 | A |
5013424 | James, Jr. et al. | May 1991 | A |
5013793 | Wang et al. | May 1991 | A |
5019652 | Taylor et al. | May 1991 | A |
5026934 | Bains et al. | Jun 1991 | A |
5026937 | Bricker | Jun 1991 | A |
5026944 | Allenger et al. | Jun 1991 | A |
5034566 | Ishino et al. | Jul 1991 | A |
5043502 | Martindale et al. | Aug 1991 | A |
5055235 | Brackenridge et al. | Oct 1991 | A |
5055625 | Neidiffer et al. | Oct 1991 | A |
5055633 | Volles | Oct 1991 | A |
5055634 | Volles | Oct 1991 | A |
5059744 | Harandi et al. | Oct 1991 | A |
5068478 | Miller et al. | Nov 1991 | A |
5071449 | Sircar | Dec 1991 | A |
5071815 | Wallace et al. | Dec 1991 | A |
5073656 | Chafin et al. | Dec 1991 | A |
5073657 | Warren | Dec 1991 | A |
5082473 | Keefer | Jan 1992 | A |
5082816 | Teller et al. | Jan 1992 | A |
5085674 | Leavitt | Feb 1992 | A |
5087779 | Nubel et al. | Feb 1992 | A |
5087786 | Nubel et al. | Feb 1992 | A |
5087787 | Kimble et al. | Feb 1992 | A |
5093533 | Wilson | Mar 1992 | A |
5093542 | Gaffney | Mar 1992 | A |
5096469 | Keefer | Mar 1992 | A |
5097083 | Stauffer | Mar 1992 | A |
5099084 | Stauffer | Mar 1992 | A |
5105045 | Kimble et al. | Apr 1992 | A |
5105046 | Washecheck | Apr 1992 | A |
5107032 | Erb et al. | Apr 1992 | A |
5107051 | Pannell | Apr 1992 | A |
5107061 | Ou et al. | Apr 1992 | A |
5108579 | Casci | Apr 1992 | A |
5118899 | Kimble et al. | Jun 1992 | A |
5120332 | Wells | Jun 1992 | A |
5132343 | Zwecker et al. | Jul 1992 | A |
5138112 | Gosling et al. | Aug 1992 | A |
5139991 | Taylor et al. | Aug 1992 | A |
5146027 | Gaffney | Sep 1992 | A |
5157189 | Karra | Oct 1992 | A |
5160502 | Kimble et al. | Nov 1992 | A |
5166452 | Gradl et al. | Nov 1992 | A |
5175382 | Hebgen et al. | Dec 1992 | A |
5178748 | Casci et al. | Jan 1993 | A |
5185479 | Stauffer | Feb 1993 | A |
5188725 | Harandi | Feb 1993 | A |
5191142 | Marshall et al. | Mar 1993 | A |
5194244 | Brownscombe et al. | Mar 1993 | A |
5202506 | Kirchner et al. | Apr 1993 | A |
5202511 | Salinas, III et al. | Apr 1993 | A |
5208402 | Wilson | May 1993 | A |
5210357 | Kolts et al. | May 1993 | A |
5215648 | Zones et al. | Jun 1993 | A |
5223471 | Washecheck | Jun 1993 | A |
5228888 | Gmelin et al. | Jul 1993 | A |
5233113 | Periana et al. | Aug 1993 | A |
5237115 | Makovec et al. | Aug 1993 | A |
5243098 | Miller et al. | Sep 1993 | A |
5243114 | Johnson et al. | Sep 1993 | A |
5245109 | Kaminsky et al. | Sep 1993 | A |
5254772 | Dukat et al. | Oct 1993 | A |
5254790 | Thomas et al. | Oct 1993 | A |
5264635 | Le et al. | Nov 1993 | A |
5268518 | West et al. | Dec 1993 | A |
5276226 | Horvath et al. | Jan 1994 | A |
5276240 | Timmons et al. | Jan 1994 | A |
5276242 | Wu | Jan 1994 | A |
5284990 | Peterson et al. | Feb 1994 | A |
5300126 | Brown et al. | Apr 1994 | A |
5306855 | Periana et al. | Apr 1994 | A |
5316995 | Kaminsky et al. | May 1994 | A |
5319132 | Ozawa et al. | Jun 1994 | A |
5334777 | Miller et al. | Aug 1994 | A |
5345021 | Casci et al. | Sep 1994 | A |
5354916 | Horvath et al. | Oct 1994 | A |
5354931 | Jan et al. | Oct 1994 | A |
5366949 | Schubert | Nov 1994 | A |
5371313 | Ostrowicki | Dec 1994 | A |
5382704 | Krespan et al. | Jan 1995 | A |
5382743 | Beech, Jr. et al. | Jan 1995 | A |
5382744 | Abbott et al. | Jan 1995 | A |
5385650 | Howarth et al. | Jan 1995 | A |
5385718 | Casci et al. | Jan 1995 | A |
5395981 | Marker | Mar 1995 | A |
5399258 | Fletcher et al. | Mar 1995 | A |
5401890 | Parks | Mar 1995 | A |
5401894 | Brasier et al. | Mar 1995 | A |
5406017 | Withers, Jr. | Apr 1995 | A |
5411641 | Trainham et al. | May 1995 | A |
5414173 | Garces et al. | May 1995 | A |
5430210 | Grasselli et al. | Jul 1995 | A |
5430214 | Smith et al. | Jul 1995 | A |
5430219 | Sanfilippo et al. | Jul 1995 | A |
5433828 | van Velzen et al. | Jul 1995 | A |
5436378 | Masini et al. | Jul 1995 | A |
5444168 | Brown | Aug 1995 | A |
5446234 | Casci et al. | Aug 1995 | A |
5453557 | Harley et al. | Sep 1995 | A |
5456822 | Marcilly et al. | Oct 1995 | A |
5457255 | Kumata et al. | Oct 1995 | A |
5464799 | Casci et al. | Nov 1995 | A |
5465699 | Voigt | Nov 1995 | A |
5470377 | Whitlock | Nov 1995 | A |
5480629 | Thompson et al. | Jan 1996 | A |
5486627 | Quarderer, Jr. et al. | Jan 1996 | A |
5489719 | Le et al. | Feb 1996 | A |
5489727 | Randolph et al. | Feb 1996 | A |
5500297 | Thompson et al. | Mar 1996 | A |
5510525 | Sen et al. | Apr 1996 | A |
5523503 | Funk et al. | Jun 1996 | A |
5525230 | Wrigley et al. | Jun 1996 | A |
5538540 | Whitlock | Jul 1996 | A |
5563313 | Chung et al. | Oct 1996 | A |
5565092 | Pannell et al. | Oct 1996 | A |
5565616 | Li et al. | Oct 1996 | A |
5571762 | Clerici et al. | Nov 1996 | A |
5571885 | Chung et al. | Nov 1996 | A |
5599381 | Whitlock | Feb 1997 | A |
5600043 | Johnston et al. | Feb 1997 | A |
5600045 | Van Der Aalst et al. | Feb 1997 | A |
5609654 | Le et al. | Mar 1997 | A |
5633419 | Spencer et al. | May 1997 | A |
5639930 | Penick | Jun 1997 | A |
5653956 | Zones | Aug 1997 | A |
5656149 | Zones et al. | Aug 1997 | A |
5661097 | Spencer et al. | Aug 1997 | A |
5663465 | Clegg et al. | Sep 1997 | A |
5663474 | Pham et al. | Sep 1997 | A |
5674464 | Van Velzen et al. | Oct 1997 | A |
5675046 | Ohno et al. | Oct 1997 | A |
5675052 | Menon et al. | Oct 1997 | A |
5679134 | Brugerolle et al. | Oct 1997 | A |
5679879 | Mercier et al. | Oct 1997 | A |
5684213 | Nemphos et al. | Nov 1997 | A |
5693191 | Pividal et al. | Dec 1997 | A |
5695890 | Thompson et al. | Dec 1997 | A |
5698747 | Godwin et al. | Dec 1997 | A |
5705712 | Frey et al. | Jan 1998 | A |
5705728 | Viswanathan et al. | Jan 1998 | A |
5705729 | Huang | Jan 1998 | A |
5708246 | Camaioni et al. | Jan 1998 | A |
5720858 | Noceti et al. | Feb 1998 | A |
5728897 | Buysch et al. | Mar 1998 | A |
5728905 | Clegg et al. | Mar 1998 | A |
5734073 | Chambers et al. | Mar 1998 | A |
5741949 | Mack | Apr 1998 | A |
5744669 | Kalnes et al. | Apr 1998 | A |
5750801 | Buysch et al. | May 1998 | A |
5770175 | Zones | Jun 1998 | A |
5776871 | Cothran et al. | Jul 1998 | A |
5780703 | Chang et al. | Jul 1998 | A |
5782936 | Riley | Jul 1998 | A |
5798314 | Spencer et al. | Aug 1998 | A |
5814715 | Chen et al. | Sep 1998 | A |
5817904 | Vic et al. | Oct 1998 | A |
5821394 | Schoebrechts et al. | Oct 1998 | A |
5847224 | Koga et al. | Dec 1998 | A |
5849978 | Benazzi et al. | Dec 1998 | A |
5866735 | Cheung et al. | Feb 1999 | A |
5882614 | Taylor, Jr. et al. | Mar 1999 | A |
5895831 | Brasier et al. | Apr 1999 | A |
5898086 | Harris | Apr 1999 | A |
5905169 | Jacobson | May 1999 | A |
5906892 | Thompson et al. | May 1999 | A |
5908963 | Voss et al. | Jun 1999 | A |
5928488 | Newman | Jul 1999 | A |
5952538 | Vaughn et al. | Sep 1999 | A |
5959170 | Withers, Jr. et al. | Sep 1999 | A |
5968236 | Bassine | Oct 1999 | A |
5969195 | Stabel et al. | Oct 1999 | A |
5977402 | Sekiguchi et al. | Nov 1999 | A |
5983476 | Eshelman et al. | Nov 1999 | A |
5986158 | Van Broekhoven et al. | Nov 1999 | A |
5994604 | Reagen et al. | Nov 1999 | A |
5998679 | Miller | Dec 1999 | A |
5998686 | Clem et al. | Dec 1999 | A |
6002059 | Hellring et al. | Dec 1999 | A |
6015867 | Fushimi et al. | Jan 2000 | A |
6018088 | Olah | Jan 2000 | A |
6022929 | Chen et al. | Feb 2000 | A |
6034288 | Scott et al. | Mar 2000 | A |
6056804 | Keefer et al. | May 2000 | A |
6068679 | Zheng | May 2000 | A |
6072091 | Cosyns et al. | Jun 2000 | A |
6087294 | Klabunde et al. | Jul 2000 | A |
6090312 | Ziaka et al. | Jul 2000 | A |
6093306 | Hanrahan et al. | Jul 2000 | A |
6096932 | Subramanian | Aug 2000 | A |
6096933 | Cheung et al. | Aug 2000 | A |
6103215 | Zones et al. | Aug 2000 | A |
6107561 | Thompson | Aug 2000 | A |
6117371 | Mack | Sep 2000 | A |
6124514 | Emmrich et al. | Sep 2000 | A |
6127588 | Kimble et al. | Oct 2000 | A |
6130260 | Hall et al. | Oct 2000 | A |
6143939 | Farcasiu et al. | Nov 2000 | A |
6169218 | Hearn et al. | Jan 2001 | B1 |
6180841 | Fatutto et al. | Jan 2001 | B1 |
6187871 | Thompson et al. | Feb 2001 | B1 |
6187983 | Sun | Feb 2001 | B1 |
6203712 | Bronner et al. | Mar 2001 | B1 |
6207864 | Henningsen et al. | Mar 2001 | B1 |
6225517 | Nascimento et al. | May 2001 | B1 |
6248218 | Linkous et al. | Jun 2001 | B1 |
6265505 | McConville et al. | Jul 2001 | B1 |
6281405 | Davis et al. | Aug 2001 | B1 |
6320085 | Arvai et al. | Nov 2001 | B1 |
6337063 | Rouleau et al. | Jan 2002 | B1 |
6342200 | Rouleau et al. | Jan 2002 | B1 |
6368490 | Gestermann | Apr 2002 | B1 |
6369283 | Guram et al. | Apr 2002 | B1 |
6372949 | Brown et al. | Apr 2002 | B1 |
6376731 | Evans et al. | Apr 2002 | B1 |
6380328 | McConville et al. | Apr 2002 | B1 |
6380423 | Banning et al. | Apr 2002 | B2 |
6380444 | Bjerrum et al. | Apr 2002 | B1 |
6395945 | Randolph | May 2002 | B1 |
6403840 | Zhou et al. | Jun 2002 | B1 |
6406523 | Connor et al. | Jun 2002 | B1 |
6423211 | Randolph et al. | Jul 2002 | B1 |
6426441 | Randolph et al. | Jul 2002 | B1 |
6426442 | Ichikawa et al. | Jul 2002 | B1 |
6452058 | Schweizer et al. | Sep 2002 | B1 |
6455650 | Lipian et al. | Sep 2002 | B1 |
6462243 | Zhou et al. | Oct 2002 | B1 |
6465696 | Zhou et al. | Oct 2002 | B1 |
6465699 | Grosso | Oct 2002 | B1 |
6472345 | Hintermann et al. | Oct 2002 | B2 |
6472572 | Zhou et al. | Oct 2002 | B1 |
6475463 | Elomari et al. | Nov 2002 | B1 |
6475464 | Rouleau et al. | Nov 2002 | B1 |
6479705 | Murata et al. | Nov 2002 | B2 |
6482997 | Petit-Clair et al. | Nov 2002 | B2 |
6486368 | Zhou et al. | Nov 2002 | B1 |
6491809 | Briot et al. | Dec 2002 | B1 |
6495484 | Holtcamp | Dec 2002 | B1 |
6509485 | Mul et al. | Jan 2003 | B2 |
6511526 | Jagger et al. | Jan 2003 | B2 |
6514319 | Keefer et al. | Feb 2003 | B2 |
6518474 | Sanderson et al. | Feb 2003 | B1 |
6518476 | Culp et al. | Feb 2003 | B1 |
6525228 | Chauvin et al. | Feb 2003 | B2 |
6525230 | Grosso | Feb 2003 | B2 |
6528693 | Gandy et al. | Mar 2003 | B1 |
6538162 | Chang et al. | Mar 2003 | B2 |
6540905 | Elomari | Apr 2003 | B1 |
6545191 | Stauffer | Apr 2003 | B1 |
6547958 | Elomari | Apr 2003 | B1 |
6548040 | Rouleau et al. | Apr 2003 | B1 |
6552241 | Randolph et al. | Apr 2003 | B1 |
6566572 | Okamoto et al. | May 2003 | B2 |
6572829 | Linkous et al. | Jun 2003 | B2 |
6585953 | Roberts et al. | Jul 2003 | B2 |
6616830 | Elomari | Sep 2003 | B2 |
6620757 | McConville et al. | Sep 2003 | B2 |
6632971 | Brown et al. | Oct 2003 | B2 |
6635793 | Mul et al. | Oct 2003 | B2 |
6641644 | Jagger et al. | Nov 2003 | B2 |
6646102 | Boriack et al. | Nov 2003 | B2 |
6669846 | Perriello | Dec 2003 | B2 |
6672572 | Werlen | Jan 2004 | B2 |
6679986 | Da Silva et al. | Jan 2004 | B1 |
6680415 | Gulotty, Jr. et al. | Jan 2004 | B1 |
6692626 | Keefer et al. | Feb 2004 | B2 |
6692723 | Rouleau et al. | Feb 2004 | B2 |
6710213 | Aoki et al. | Mar 2004 | B2 |
6713087 | Tracy et al. | Mar 2004 | B2 |
6713655 | Yilmaz et al. | Mar 2004 | B2 |
RE38493 | Keefer et al. | Apr 2004 | E |
6723808 | Holtcamp | Apr 2004 | B2 |
6727400 | Messier et al. | Apr 2004 | B2 |
6740146 | Simonds | May 2004 | B2 |
6753390 | Ehrman et al. | Jun 2004 | B2 |
6765120 | Weber et al. | Jul 2004 | B2 |
6797845 | Hickman et al. | Sep 2004 | B1 |
6797851 | Martens et al. | Sep 2004 | B2 |
6821924 | Gulotty, Jr. et al. | Nov 2004 | B2 |
6822123 | Stauffer | Nov 2004 | B2 |
6822125 | Lee et al. | Nov 2004 | B2 |
6825307 | Goodall | Nov 2004 | B2 |
6825383 | Dewkar et al. | Nov 2004 | B1 |
6831032 | Spaether | Dec 2004 | B2 |
6838576 | Wicki et al. | Jan 2005 | B1 |
6841063 | Elomari | Jan 2005 | B2 |
6852896 | Stauffer | Feb 2005 | B2 |
6866950 | Connor et al. | Mar 2005 | B2 |
6869903 | Matsunaga | Mar 2005 | B2 |
6875339 | Rangarajan et al. | Apr 2005 | B2 |
6878853 | Tanaka et al. | Apr 2005 | B2 |
6888013 | Paparatto et al. | May 2005 | B2 |
6900363 | Harth et al. | May 2005 | B2 |
6902602 | Keefer et al. | Jun 2005 | B2 |
6903171 | Rhodes et al. | Jun 2005 | B2 |
6909024 | Jones et al. | Jun 2005 | B1 |
6921597 | Keefer et al. | Jul 2005 | B2 |
6933417 | Henley et al. | Aug 2005 | B1 |
6946566 | Yaegashi et al. | Sep 2005 | B2 |
6953868 | Boaen et al. | Oct 2005 | B2 |
6953870 | Yan et al. | Oct 2005 | B2 |
6953873 | Cortright et al. | Oct 2005 | B2 |
6956140 | Ehrenfeld | Oct 2005 | B2 |
6958306 | Holtcamp | Oct 2005 | B2 |
6984763 | Schweizer et al. | Jan 2006 | B2 |
7001872 | Pyecroft et al. | Feb 2006 | B2 |
7002050 | Santiago Fernandez et al. | Feb 2006 | B2 |
7011811 | Elomari | Mar 2006 | B2 |
7019182 | Grosso | Mar 2006 | B2 |
7026145 | Mizrahi et al. | Apr 2006 | B2 |
7026519 | Santiago Fernandez et al. | Apr 2006 | B2 |
7037358 | Babicki et al. | May 2006 | B2 |
7045670 | Johnson et al. | May 2006 | B2 |
7049388 | Boriack et al. | May 2006 | B2 |
7053252 | Boussand et al. | May 2006 | B2 |
7057081 | Allison et al. | Jun 2006 | B2 |
7060865 | Ding et al. | Jun 2006 | B2 |
7064238 | Waycuilis | Jun 2006 | B2 |
7064240 | Ohno et al. | Jun 2006 | B2 |
7067448 | Weitkamp et al. | Jun 2006 | B1 |
7083714 | Elomari | Aug 2006 | B2 |
7084308 | Stauffer | Aug 2006 | B1 |
7091270 | Zilberman et al. | Aug 2006 | B2 |
7091387 | Fong et al. | Aug 2006 | B2 |
7091391 | Stauffer | Aug 2006 | B2 |
7094936 | Owens et al. | Aug 2006 | B1 |
7098371 | Mack et al. | Aug 2006 | B2 |
7105710 | Boons et al. | Sep 2006 | B2 |
7138534 | Forlin et al. | Nov 2006 | B2 |
7141708 | Marsella et al. | Nov 2006 | B2 |
7145045 | Harmsen et al. | Dec 2006 | B2 |
7148356 | Smith, III et al. | Dec 2006 | B2 |
7148390 | Zhou et al. | Dec 2006 | B2 |
7151199 | Martens et al. | Dec 2006 | B2 |
7161050 | Sherman et al. | Jan 2007 | B2 |
7169730 | Ma et al. | Jan 2007 | B2 |
7176340 | Van Broekhoven et al. | Feb 2007 | B2 |
7176342 | Bellussi et al. | Feb 2007 | B2 |
7182871 | Perriello | Feb 2007 | B2 |
7193093 | Murray et al. | Mar 2007 | B2 |
7196239 | Van Egmond et al. | Mar 2007 | B2 |
7199083 | Zevallos | Apr 2007 | B2 |
7199255 | Murray et al. | Apr 2007 | B2 |
7208641 | Nagasaki et al. | Apr 2007 | B2 |
7214750 | McDonald et al. | May 2007 | B2 |
7220391 | Huang et al. | May 2007 | B1 |
7226569 | Elomari | Jun 2007 | B2 |
7226576 | Elomari | Jun 2007 | B2 |
7230150 | Grosso et al. | Jun 2007 | B2 |
7230151 | Martens et al. | Jun 2007 | B2 |
7232872 | Shaffer et al. | Jun 2007 | B2 |
7238846 | Janssen et al. | Jul 2007 | B2 |
7244795 | Agapiou et al. | Jul 2007 | B2 |
7244867 | Waycuilis | Jul 2007 | B2 |
7250107 | Benazzi et al. | Jul 2007 | B2 |
7250542 | Smith, Jr. et al. | Jul 2007 | B2 |
7252920 | Kurokawa et al. | Aug 2007 | B2 |
7253327 | Janssens et al. | Aug 2007 | B2 |
7253328 | Stauffer | Aug 2007 | B2 |
7265193 | Weng et al. | Sep 2007 | B2 |
7267758 | Benazzi et al. | Sep 2007 | B2 |
7268263 | Frey et al. | Sep 2007 | B1 |
7271303 | Sechrist et al. | Sep 2007 | B1 |
7273957 | Bakshi et al. | Sep 2007 | B2 |
7282603 | Richards | Oct 2007 | B2 |
7285698 | Liu et al. | Oct 2007 | B2 |
7304193 | Frey et al. | Dec 2007 | B1 |
7342144 | Kaizik et al. | Mar 2008 | B2 |
7348295 | Zones et al. | Mar 2008 | B2 |
7348464 | Waycuilis | Mar 2008 | B2 |
7357904 | Zones et al. | Apr 2008 | B2 |
7361794 | Grosso | Apr 2008 | B2 |
7365102 | Weissman | Apr 2008 | B1 |
7390395 | Elomari | Jun 2008 | B2 |
7560607 | Waycuilis | Jul 2009 | B2 |
7674941 | Waycuilis et al. | Mar 2010 | B2 |
7713510 | Harrod et al. | May 2010 | B2 |
7880041 | Waycuilis | Feb 2011 | B2 |
8008535 | Waycuilis | Aug 2011 | B2 |
8173851 | Waycuilis et al. | May 2012 | B2 |
8198495 | Waycuilis et al. | Jun 2012 | B2 |
8232441 | Waycuilis | Jul 2012 | B2 |
20020102672 | Mizrahi | Aug 2002 | A1 |
20020193649 | O'Rear et al. | Dec 2002 | A1 |
20020198416 | Zhou et al. | Dec 2002 | A1 |
20030004380 | Grumann | Jan 2003 | A1 |
20030065239 | Zhu | Apr 2003 | A1 |
20030069452 | Sherman et al. | Apr 2003 | A1 |
20030078456 | Yilmaz et al. | Apr 2003 | A1 |
20030120121 | Sherman et al. | Jun 2003 | A1 |
20030125589 | Grosso | Jul 2003 | A1 |
20030166973 | Zhou et al. | Sep 2003 | A1 |
20040006246 | Sherman et al. | Jan 2004 | A1 |
20040062705 | Leduc | Apr 2004 | A1 |
20040152929 | Clarke | Aug 2004 | A1 |
20040158107 | Aoki | Aug 2004 | A1 |
20040158108 | Snoble | Aug 2004 | A1 |
20040171779 | Matyjaszewski et al. | Sep 2004 | A1 |
20040187684 | Elomari | Sep 2004 | A1 |
20040188271 | Ramachandraiah et al. | Sep 2004 | A1 |
20040188324 | Elomari | Sep 2004 | A1 |
20040220433 | Van Der Heide | Nov 2004 | A1 |
20050027084 | Clarke | Feb 2005 | A1 |
20050038310 | Lorkovic et al. | Feb 2005 | A1 |
20050042159 | Elomari | Feb 2005 | A1 |
20050047927 | Lee et al. | Mar 2005 | A1 |
20050148805 | Jones | Jul 2005 | A1 |
20050171393 | Lorkovic | Aug 2005 | A1 |
20050192468 | Sherman et al. | Sep 2005 | A1 |
20050215837 | Hoffpauir | Sep 2005 | A1 |
20050234276 | Waycuilis | Oct 2005 | A1 |
20050234277 | Waycuilis | Oct 2005 | A1 |
20050245771 | Fong et al. | Nov 2005 | A1 |
20050245772 | Fong | Nov 2005 | A1 |
20050245777 | Fong | Nov 2005 | A1 |
20050267224 | Herling | Dec 2005 | A1 |
20060025617 | Begley | Feb 2006 | A1 |
20060100469 | Waycuilis | May 2006 | A1 |
20060135823 | Jun | Jun 2006 | A1 |
20060138025 | Zones | Jun 2006 | A1 |
20060138026 | Chen | Jun 2006 | A1 |
20060149116 | Slaugh | Jul 2006 | A1 |
20060229228 | Komon et al. | Oct 2006 | A1 |
20060229475 | Weiss et al. | Oct 2006 | A1 |
20060270863 | Reiling | Nov 2006 | A1 |
20060288690 | Elomari | Dec 2006 | A1 |
20070004955 | Kay | Jan 2007 | A1 |
20070078285 | Dagle | Apr 2007 | A1 |
20070100189 | Stauffer | May 2007 | A1 |
20070129584 | Basset | Jun 2007 | A1 |
20070142680 | Ayoub | Jun 2007 | A1 |
20070148067 | Zones | Jun 2007 | A1 |
20070148086 | Zones | Jun 2007 | A1 |
20070149778 | Zones | Jun 2007 | A1 |
20070149789 | Zones | Jun 2007 | A1 |
20070149819 | Zones | Jun 2007 | A1 |
20070149824 | Zones | Jun 2007 | A1 |
20070149837 | Zones | Jun 2007 | A1 |
20070197801 | Bolk | Aug 2007 | A1 |
20070197847 | Liu | Aug 2007 | A1 |
20070213545 | Bolk | Sep 2007 | A1 |
20070238905 | Arredondo | Oct 2007 | A1 |
20070238909 | Gadewar et al. | Oct 2007 | A1 |
20070276168 | Garel | Nov 2007 | A1 |
20070284284 | Zones | Dec 2007 | A1 |
20080022717 | Yoshida et al. | Jan 2008 | A1 |
20080152555 | Wang et al. | Jun 2008 | A1 |
20080171898 | Waycuilis | Jul 2008 | A1 |
20080183022 | Waycuilis | Jul 2008 | A1 |
20080188697 | Lorkovic | Aug 2008 | A1 |
20080200740 | Waycuilis | Aug 2008 | A1 |
20080275284 | Waycuilis | Nov 2008 | A1 |
20080314758 | Grosso et al. | Dec 2008 | A1 |
20090005620 | Waycuilis et al. | Jan 2009 | A1 |
20090163749 | Li et al. | Jun 2009 | A1 |
20090247796 | Waycuilis et al. | Oct 2009 | A1 |
20090270655 | Fong et al. | Oct 2009 | A1 |
20090306443 | Stark et al. | Dec 2009 | A1 |
20090312586 | Waycuilis et al. | Dec 2009 | A1 |
20090326292 | Waycuilis | Dec 2009 | A1 |
20100030005 | Sauer et al. | Feb 2010 | A1 |
20100087686 | Fong et al. | Apr 2010 | A1 |
20100096588 | Gadewar et al. | Apr 2010 | A1 |
20100099930 | Stoimenov et al. | Apr 2010 | A1 |
20100105972 | Lorkovic | Apr 2010 | A1 |
20100234637 | Fong et al. | Sep 2010 | A1 |
20110015458 | Waycuilis et al. | Jan 2011 | A1 |
20110071326 | Waycuilis | Mar 2011 | A1 |
20110218372 | Waycuilis et al. | Sep 2011 | A1 |
20110218374 | Waycuilis | Sep 2011 | A1 |
20120141356 | Brickey et al. | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
1099656 | Apr 1981 | CA |
1101441 | May 1981 | CA |
1202610 | Apr 1986 | CA |
2542857 | May 2005 | CA |
2236126 | Aug 2006 | CA |
2203115 | Sep 2006 | CA |
2510093 | Dec 2006 | CA |
0164798 | Dec 1985 | EP |
0418971 | Mar 1991 | EP |
0418974 | Mar 1991 | EP |
0418975 | Mar 1991 | EP |
0510238 | Oct 1992 | EP |
0526908 | Feb 1993 | EP |
0346612 | Aug 1993 | EP |
0560546 | Sep 1993 | EP |
0976705 | Jul 1998 | EP |
1186591 | Mar 2002 | EP |
1253126 | Oct 2002 | EP |
1312411 | May 2003 | EP |
1235769 | May 2004 | EP |
1440939 | Jul 2004 | EP |
1235772 | Jan 2005 | EP |
1661620 | May 2006 | EP |
1760057 | Mar 2007 | EP |
1689728 | Apr 2007 | EP |
1808227 | Jul 2007 | EP |
1837320 | Sep 2007 | EP |
5125 | Jan 1912 | GB |
156122 | Mar 1922 | GB |
294100 | Jun 1929 | GB |
363009 | Dec 1931 | GB |
402928 | Dec 1933 | GB |
474922 | Nov 1937 | GB |
536491 | May 1941 | GB |
553950 | Jun 1943 | GB |
586483 | Mar 1947 | GB |
775590 | May 1957 | GB |
793214 | Apr 1958 | GB |
796048 | Jun 1958 | GB |
796085 | Jun 1958 | GB |
883256 | Nov 1961 | GB |
883256 | Nov 1961 | GB |
930341 | Jul 1963 | GB |
950975 | Mar 1964 | GB |
950976 | Mar 1964 | GB |
991303 | May 1965 | GB |
995960 | Jun 1965 | GB |
1015033 | Dec 1965 | GB |
1104294 | Feb 1968 | GB |
1133752 | Nov 1968 | GB |
1172002 | Nov 1969 | GB |
1212240 | Nov 1970 | GB |
1233299 | May 1971 | GB |
1253618 | Nov 1971 | GB |
1263806 | Feb 1972 | GB |
1446803 | Aug 1976 | GB |
1542112 | Mar 1979 | GB |
2095243 | Sep 1982 | GB |
2095245 | Sep 1982 | GB |
2095249 | Sep 1982 | GB |
2116546 | Sep 1982 | GB |
2120249 | Nov 1983 | GB |
2185754 | Jul 1987 | GB |
2191214 | Dec 1987 | GB |
694483 | Oct 1979 | SU |
8300859 | Mar 1983 | WO |
8504863 | Nov 1985 | WO |
8504867 | Nov 1985 | WO |
9008120 | Jul 1990 | WO |
9008752 | Aug 1990 | WO |
9118856 | Dec 1991 | WO |
9203401 | Mar 1992 | WO |
9212946 | Aug 1992 | WO |
9316798 | Sep 1993 | WO |
9622263 | Jul 1996 | WO |
9744302 | Nov 1997 | WO |
9812165 | Mar 1998 | WO |
9907443 | Feb 1999 | WO |
0007718 | Feb 2000 | WO |
0009261 | Feb 2000 | WO |
0114300 | Mar 2001 | WO |
0138275 | May 2001 | WO |
0144149 | Jun 2001 | WO |
02094749 | Nov 2002 | WO |
02094750 | Nov 2002 | WO |
02094751 | Nov 2002 | WO |
02094752 | Nov 2002 | WO |
03000635 | Jan 2003 | WO |
03002251 | Jan 2003 | WO |
03018524 | Mar 2003 | WO |
03020676 | Mar 2003 | WO |
03022827 | Mar 2003 | WO |
03043575 | May 2003 | WO |
03051813 | Jun 2003 | WO |
03062143 | Jul 2003 | WO |
03062172 | Jul 2003 | WO |
03078366 | Sep 2003 | WO |
2004018093 | Mar 2004 | WO |
2004067487 | Aug 2004 | WO |
2005014168 | Feb 2005 | WO |
2005019143 | Mar 2005 | WO |
2005021468 | Mar 2005 | WO |
2005035121 | Apr 2005 | WO |
2005037758 | Apr 2005 | WO |
2005054120 | Jun 2005 | WO |
2005056525 | Jun 2005 | WO |
2005058782 | Jun 2005 | WO |
2005090272 | Sep 2005 | WO |
2005095310 | Oct 2005 | WO |
2005104689 | Nov 2005 | WO |
2005105709 | Nov 2005 | WO |
2005105715 | Nov 2005 | WO |
2005110953 | Nov 2005 | WO |
2005113437 | Dec 2005 | WO |
2005113440 | Dec 2005 | WO |
2006007093 | Jan 2006 | WO |
2006015824 | Feb 2006 | WO |
2006019399 | Feb 2006 | WO |
2006020234 | Feb 2006 | WO |
2006036293 | Apr 2006 | WO |
2006039213 | Apr 2006 | WO |
2006039354 | Apr 2006 | WO |
2006043075 | Apr 2006 | WO |
2006053345 | May 2006 | WO |
2006-067155 | Jun 2006 | WO |
2006067188 | Jun 2006 | WO |
2006067190 | Jun 2006 | WO |
2006067191 | Jun 2006 | WO |
2006067192 | Jun 2006 | WO |
2006067193 | Jun 2006 | WO |
2006069107 | Jun 2006 | WO |
2006071354 | Jul 2006 | WO |
2006076942 | Jul 2006 | WO |
2006083427 | Aug 2006 | WO |
2006-100312 | Sep 2006 | WO |
2006104909 | Oct 2006 | WO |
2006104914 | Oct 2006 | WO |
2006111997 | Oct 2006 | WO |
2006113205 | Oct 2006 | WO |
2006118935 | Nov 2006 | WO |
2007001934 | Jan 2007 | WO |
2007017900 | Feb 2007 | WO |
2007044139 | Apr 2007 | WO |
2007046986 | Apr 2007 | WO |
2007050745 | May 2007 | WO |
2007071046 | Jun 2007 | WO |
2007079038 | Jul 2007 | WO |
2007091009 | Aug 2007 | WO |
2007094995 | Aug 2007 | WO |
2007107031 | Sep 2007 | WO |
2007111997 | Oct 2007 | WO |
2007114479 | Oct 2007 | WO |
2007125332 | Nov 2007 | WO |
2007130054 | Nov 2007 | WO |
2007130055 | Nov 2007 | WO |
2007141295 | Dec 2007 | WO |
2007142745 | Dec 2007 | WO |
2008036562 | Mar 2008 | WO |
2008036563 | Mar 2008 | WO |
2008106319 | Sep 2008 | WO |
2008157043 | Dec 2008 | WO |
2008157044 | Dec 2008 | WO |
2008157045 | Dec 2008 | WO |
2008157046 | Dec 2008 | WO |
2008157047 | Dec 2008 | WO |
2009152403 | Dec 2009 | WO |
2009152405 | Dec 2009 | WO |
2009152408 | Dec 2009 | WO |
2010009376 | Jan 2010 | WO |
2011008573 | Jan 2011 | WO |
2011109244 | Sep 2011 | WO |
2011159490 | Dec 2011 | WO |
Number | Date | Country | |
---|---|---|---|
20090308759 A1 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
61061475 | Jun 2008 | US |